Your browser doesn't support javascript.
Stroke in COVID-19: A systematic review and meta-analysis.
Nannoni, Stefania; de Groot, Rosa; Bell, Steven; Markus, Hugh S.
  • Nannoni S; Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, UK.
  • de Groot R; Donor Medicine Research, Sanquin Research, Amsterdam, the Netherlands.
  • Bell S; Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, UK.
  • Markus HS; Stroke Research Group, Department of Clinical Neurosciences, University of Cambridge, UK.
Int J Stroke ; 16(2): 137-149, 2021 02.
Article in English | MEDLINE | ID: covidwho-1027186
ABSTRACT

BACKGROUND:

Coronavirus disease 2019 (COVID-19) has become a global pandemic, affecting millions of people. However, the relationship between COVID-19 and acute cerebrovascular diseases is unclear.

AIMS:

We aimed to characterize the incidence, risk factors, clinical-radiological manifestations, and outcome of COVID-19-associated stroke.

METHODS:

Three medical databases were systematically reviewed for published articles on acute cerebrovascular diseases in COVID-19 (December 2019-September 2020). The review protocol was previously registered (PROSPERO ID = CRD42020185476). Data were extracted from articles reporting ≥5 stroke cases in COVID-19. We complied with the PRISMA guidelines and used the Newcastle-Ottawa Scale to assess data quality. Data were pooled using a random-effect model. SUMMARY OF REVIEW Of 2277 initially identified articles, 61 (2.7%) were entered in the meta-analysis. Out of 108,571 patients with COVID-19, acute CVD occurred in 1.4% (95%CI 1.0-1.9). The most common manifestation was acute ischemic stroke (87.4%); intracerebral hemorrhage was less common (11.6%). Patients with COVID-19 developing acute cerebrovascular diseases, compared to those who did not, were older (pooled median difference = 4.8 years; 95%CI 1.7-22.4), more likely to have hypertension (OR = 7.35; 95%CI 1.94-27.87), diabetes mellitus (OR = 5.56; 95%CI 3.34-9.24), coronary artery disease (OR = 3.12; 95%CI 1.61-6.02), and severe infection (OR = 5.10; 95%CI 2.72-9.54). Compared to individuals who experienced a stroke without the infection, patients with COVID-19 and stroke were younger (pooled median difference = -6.0 years; 95%CI -12.3 to -1.4), had higher NIHSS (pooled median difference = 5; 95%CI 3-9), higher frequency of large vessel occlusion (OR = 2.73; 95%CI 1.63-4.57), and higher in-hospital mortality rate (OR = 5.21; 95%CI 3.43-7.90).

CONCLUSIONS:

Acute cerebrovascular diseases are not uncommon in patients with COVID-19, especially in those whom are severely infected and have pre-existing vascular risk factors. The pattern of large vessel occlusion and multi-territory infarcts suggests that cerebral thrombosis and/or thromboembolism could be possible causative pathways for the disease.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Brain Ischemia / Stroke / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Int J Stroke Year: 2021 Document Type: Article Affiliation country: 1747493020972922

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Brain Ischemia / Stroke / COVID-19 Type of study: Observational study / Prognostic study / Randomized controlled trials / Reviews / Systematic review/Meta Analysis Limits: Humans Language: English Journal: Int J Stroke Year: 2021 Document Type: Article Affiliation country: 1747493020972922